Collectively, these new data highlight the importance of HIF-1α in populations at high risk for gastric cancer, but also demonstrate that use of a PHD inhibitor, DMOG, and consequent stabilization of HIF-1α is protective in H. pylori-induced gastric inflammation and injury. Here, PDC is linked to gastric cancer.